CTOs on the Move

Aro Biotherapeutics

www.arobiotx.com

 
Based in Philadelphia, Aro Biotherapeutics is a biotechnology company pioneering the development of tissue-targeted genetic medicines with a platform based on a proprietary protein technology called Centyrins. The company is developing a wholly-owned pipeline of Centyrin-based therapeutic candidates and is working with industry partners to leverage Centyrins for tissue-specific targeting of therapeutics for a diverse set of diseases.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.arobiotx.com
  • 3675 Market Street Suite 200
    Philadelphia, PA USA 19104
  • Phone: n/a

Executives

Name Title Contact Details
Sukumar Sakamuri
 Chief Technology Officer Profile

Funding

Aro Biotherapeutics raised $13M on 12/11/2018
Aro Biotherapeutics raised $48M on 12/21/2020

Similar Companies

1910 Genetics

We are a biotechnology company integrating AI, computation and biological automation to accelerate the design of small molecule and protein therapeutics. Our mission is to decrease the timeline and cost of drug development, while improving the success rate of bring innovative medicines to patients in need.

Gene Logic

Gene Logic is a Gaithersburg, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Rebus Biosystems

Advanced imaging, fluidics, chemistry and bioinformatics. Innovative, robust tools for spatial omics without compromise. Rebus Esper platform available now.

Alzheon

Alzheon, Inc. is committed to developing innovative medicines by directly addressing the underlying pathology of devastating neurodegenerative disorders.

Pyramid Biosciences

Pyramid Biosciences is dedicated to discovering and developing targeted therapeutics for a wide range of disorders that are regulated by the tropomyosin receptor kinase (TRK) family.